Sei Investments Co. Purchases 7,798 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Sei Investments Co. boosted its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 2.7% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 293,265 shares of the medical device company's stock after purchasing an additional 7,798 shares during the period. Sei Investments Co. owned about 0.15% of Cooper Companies worth $26,961,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in COO. Raymond James Financial Inc. purchased a new position in shares of Cooper Companies in the 4th quarter worth approximately $64,826,000. Victory Capital Management Inc. lifted its holdings in Cooper Companies by 14.6% during the fourth quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock worth $415,985,000 after acquiring an additional 574,899 shares during the period. JPMorgan Chase & Co. boosted its position in Cooper Companies by 13.2% in the third quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company's stock worth $543,979,000 after purchasing an additional 573,908 shares during the last quarter. Wealthfront Advisers LLC grew its stake in Cooper Companies by 4,594.1% in the 4th quarter. Wealthfront Advisers LLC now owns 569,812 shares of the medical device company's stock valued at $52,383,000 after purchasing an additional 557,673 shares during the period. Finally, Alecta Tjanstepension Omsesidigt purchased a new stake in shares of Cooper Companies during the 4th quarter valued at $49,550,000. Hedge funds and other institutional investors own 24.39% of the company's stock.

Remove Ads

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on COO shares. Robert W. Baird cut their price target on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating on the stock in a report on Friday, March 7th. BNP Paribas raised shares of Cooper Companies to a "hold" rating in a research report on Thursday, March 13th. Wells Fargo & Company lifted their price target on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an "overweight" rating in a report on Friday, December 6th. JPMorgan Chase & Co. reduced their price objective on Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Friday, March 7th. Finally, Morgan Stanley lowered their target price on Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating on the stock in a research note on Friday, December 6th. Four equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $110.25.

Cooper Companies Stock Performance

COO stock traded down $1.21 during midday trading on Friday, reaching $83.77. 1,736,366 shares of the company's stock traded hands, compared to its average volume of 1,343,868. The firm has a market capitalization of $16.75 billion, a PE ratio of 42.96, a price-to-earnings-growth ratio of 2.25 and a beta of 1.02. The company has a 50-day moving average price of $89.33 and a two-hundred day moving average price of $97.29. The Cooper Companies, Inc. has a 52 week low of $77.05 and a 52 week high of $112.38. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.92. The company had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. As a group, equities analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.